• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2019

View Archived Issues

New inhibitor blocks, degrades MYC

Read More

Study identifies metabolic path from stress to anxiety

Read More

Antisense oligonucleotides inhibit nonsense-mediated RNA decay in W1282X cystic fibrosis

Read More

AVEO Oncology and Biodesix initiate CyFi-2 study of ficlatuzumab plus high-dose cytarabine

Read More

EIP Pharma releases data from the REVERSE-SD study of neflamapimod

Read More

Mologen announces the initiation of phase IIa TITAN combination trial

Read More

Positive topline data from phase III VANISH-303 registration study of oral ibrexafungerp

Read More

Voclosporin DDI study demonstrates no clinically significant interaction with MMF

Read More

Discovery and preclinical characterization of a novel anti-CD178 antibody, FBP-002

Read More

Antisense therapy with antagomiR-23b shows promise for the treatment of DM1

Read More

Novel nonhuman primate model of induced colitis

Read More

Psioxus Therapeutics presents series of oncolytic viral compounds for cancer

Read More

Recombinant human thrombomodulin evaluated for ARDS with disseminated intravascular coagulation

Read More

Merck KGaA starts phase III study of L-praziquantel orodispersible in Schistosoma-infected children

Read More

Novel gene therapy for the treatment of Alzheimer's disease

Read More

AAV encoding NUsc1 rescues memory in Alzheimer's disease model

Read More

Supernus Pharmaceuticals provides data from phase III P301 study of SPN-810

Read More

Researchers divulge new compounds for malaria

Read More

Masitinib reduces severe asthma exacerbation rate in phase III study

Read More

Constellation Pharmaceuticals patents EZH2 inhibitors

Read More

Merck & Co. synthesizes new IDO1 inhibitors

Read More

The Medicines discloses new boronic acid-based antibacterials

Read More

C4 Therapeutics discovers new cereblon ligands for cancer

Read More

Targeting acquired immunity improves brain injury recovery

Read More

Affimed's IND for AFM-24 cleared for phase I/II study in EGFR-expressing cancers

Read More

AvantGen enters collaboration to use NK cell engager platform to generate anticancer therapeutics

Read More

Promising phase I data presented for the mutant-selective KRAS G12C inhibitor MRTX-849

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe